Breakthrough in Breast Cancer Treatment: Global Study Results Offer Hope for Early-Stage Patients

20 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
A recent global study has revealed a significant advancement in the treatment of early-stage breast cancer. The study, presented at the European Society for Medical Oncology Congress, found that a drug called ribociclib (Kisqali) can reduce the risk of cancer recurrence by 28% when combined with standard endocrine therapy. This breakthrough is especially relevant for New Zealand, where breast cancer rates are among the highest in the world. With around 3,500 women diagnosed annually, this treatment offers a chance for many to live cancer-free. The study's findings emphasize the importance of early intervention, as it can prevent hundreds of women from reaching the stage of incurable disease. Patient advocates are now calling for expanded access to this treatment, as it is already publicly funded in NZ for advanced stages but not yet for early-stage patients. Learn more about this life-changing development and how it could impact breast cancer treatment globally.
Categoria
Oncology
Commenta per primo questo video.

Prossimo